Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Cannabinoid CB1 receptor | Starlite/ChEMBL | References |
Homo sapiens | cannabinoid receptor 2 (macrophage) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | Possible D-ribose-binding protein | 0.0264 | 0.4228 | 1 |
Wolbachia endosymbiont of Brugia malayi | O-methyltransferase | 0.0058 | 0.0168 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.0168 | 0.5 | |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0113 | 0.1244 | 0.1404 |
Echinococcus granulosus | geminin | 0.0177 | 0.2509 | 1 |
Brugia malayi | O-methyltransferase | 0.0058 | 0.0168 | 0.039 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0113 | 0.1244 | 0.1404 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0168 | 0.039 |
Trichomonas vaginalis | glutaminase, putative | 0.0268 | 0.4292 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0125 | 0.1491 | 0.1683 |
Loa Loa (eye worm) | glutaminase 2 | 0.0268 | 0.4292 | 1 |
Mycobacterium tuberculosis | Probable methyltransferase | 0.0058 | 0.0168 | 0.0189 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0125 | 0.1491 | 0.1683 |
Schistosoma mansoni | glutaminase | 0.0268 | 0.4292 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0049 | 0 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0125 | 0.1491 | 0.326 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0049 | 0 | 0.5 |
Brugia malayi | O-methyltransferase family protein | 0.0058 | 0.0168 | 0.039 |
Trypanosoma brucei | trypanothione reductase | 0.0049 | 0 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0049 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable catechol-O-methyltransferase | 0.05 | 0.8861 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0113 | 0.1244 | 0.1404 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0113 | 0.1244 | 0.1404 |
Plasmodium vivax | glutathione reductase, putative | 0.0049 | 0 | 0.5 |
Brugia malayi | O-methyltransferase family protein | 0.0058 | 0.0168 | 0.039 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0113 | 0.1244 | 0.1404 |
Treponema pallidum | methylgalactoside ABC transporter, periplasmic galactose-binding protein (mglB-2) | 0.0264 | 0.4228 | 0.5 |
Brugia malayi | O-methyltransferase family protein | 0.0058 | 0.0168 | 0.039 |
Loa Loa (eye worm) | glutaminase | 0.0268 | 0.4292 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.0268 | 0.4292 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0113 | 0.1244 | 0.2652 |
Treponema pallidum | methylgalactoside ABC transporter, periplasmic galactose-binding protein (mglB-1) | 0.0264 | 0.4228 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.0168 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.2509 | 0.5677 |
Loa Loa (eye worm) | O-methyltransferase | 0.0058 | 0.0168 | 0.039 |
Leishmania major | trypanothione reductase | 0.0049 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable reductase | 0.0113 | 0.1244 | 0.1404 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0125 | 0.1491 | 0.1683 |
Mycobacterium ulcerans | glutaminase | 0.0268 | 0.4292 | 0.4195 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.2509 | 0.5677 |
Echinococcus multilocularis | geminin | 0.0177 | 0.2509 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0049 | 0 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0049 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6.57 nM | Displacement of [3H]CP-55940 from CB1 receptor in Sprague-Dawley rat cerebellar membrane | ChEMBL. | 19022666 |
IC50 (binding) | > 10000 nM | Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHO cells | ChEMBL. | 19022666 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.